NCT01996293View on ClinicalTrials.gov

Pregnant Women Taking Lamictal for Bipolar Disorder

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2020

Study Completion Date

December 31, 2020

Conditions
Bipolar Disorder
Interventions
DRUG

lamotrigine

Lamotrigine will be observed in women who have already under the guidance of a physician decide to continue lamotrigine for the treatment of Bipolar Disorder

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01996293 - Pregnant Women Taking Lamictal for Bipolar Disorder | Biotech Hunter | Biotech Hunter